Protalix BioTherapeutics
PLX
#8878
Rank
NZ$0.29 B
Marketcap
NZ$3.67
Share price
1.90%
Change (1 day)
40.85%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$12.95 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.84 Million. In 2024 the company made an earning of NZ$8.93 Million a decrease over its 2023 earnings that were of NZ$20.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$12.95 M45.02%
2024 NZ$8.93 M-55.62%
2023 NZ$20.13 M-199.05%
2022 -NZ$20.33 Million-40.38%
2021 -NZ$34.1 Million-732.31%
2020 NZ$5.39 M-130.53%
2019 -NZ$17.66 Million189.85%
2018 -NZ$6.1 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$31.71 Million-32.37%
2015 -NZ$46.89 Million10.11%
2014 -NZ$42.58 Million-7.59%
2013 -NZ$46.08 Million
2011 -NZ$53.36 Million-19.39%
2010 -NZ$66.19 Million20.87%
2009 -NZ$54.76 Million32.26%
2008 -NZ$41.41 Million-5.46%
2007 -NZ$43.8 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.67 Million1.03%
2000 -NZ$0.66 Million-53.22%
1999 -NZ$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.14 B 141,889.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.36 B 10,609.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.88 B 30,346.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel